Medindia

X

BioMarin to Present at the NASDAQ OMX 23rd Investor Program

Wednesday, November 25, 2009 General News J E 4
Advertisement

Contacts:

Investors

Media

Eugenia Shen

Susan Berg

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 506-6570

(415) 506-6594

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Bioniche Strengthens the International Patent Port...
S
Centene Corporation Receives Notification of Inten...